Honorary Fellowship for Professor Chakravarthy
Professor Usha Chakravarthy will receive an Honorary Fellowship of the Royal College of Ophthalmologists at an awards ceremony in London in September 2019.
Two NetwORC UK staff among top experts in diabetes complications
Professors Tunde Peto and Usha Chakravarthy have been listed in the Top 25 experts in diabetes complications in the UK. Expertscape objectively ranks people and institutions by their expertise in more than 26,000 biomedical topics, with rankings based on scientific publications.
Dr Nicola Quinn wins at Woman in Vision
Dr Nicola Quinn, a Research Fellow based at the Belfast Ophthalmic Reading Centre, was awarded winner of the rapid fire presentation at the Woman in Vision UK conference in Liverpool recently. Her presentation was on the integration of diabetic eye screening in the haemodialysis unit in Belfast City Hospital.
New Treasurer for the European Coalition for Vision Alliance
Professor Tunde Peto, Director of CARF and the Belfast Ophthalmic Reading Centre, has been appointed Treasurer of the European Coalition for Vision Alliance which officially sits in Brussels; an EU umbrella organisation for vision.
New study proves advantages of MultiColor imaging for AMD
Professor awarded CBE in Queen's Birthday Honours
We were delighted to hear that the Director of CARF and the Belfast Ophthalmic Reading Centre, Professor Usha Chakravarthy, has been recognised in the Queen's Birthday Honours List 2016. Professor Chakravarthy has been awarded the Commander of the Order of the British Empire for services to Ophthalmology in Northern Ireland and voluntary service to Managing Eye Conditions.
NetwORC UK meeting held in Belfast
NetwORC UK celebrates 10th anniversary
NetwORC UK staff present at ARVO 2014
Queen's study into eye drug could save the NHS £85m a year
A vision for hope: Belfast study proves cancer drug can prevent blindness
Research at Queen's University finds Avastin is good treatment for eye conditions.
Cancer drug can treat blindness
A drug designed to fight cancer is as effective a treatment for a cause of blindness as a tailor-made product more than 10 times the cost, new research has found.
Cancer drug can treat blindness - QUB
Scientists at Queen's University Belfast have discovered that an anti-cancer drug could be used to treat a major cause of blindness in older people.
Queen's University Belfast-led drug study 'could save £84m'
An anti-cancer drug is as effective in treating a common cause of blindness as a more expensive specialist drug, according to a trial led by a Queen's University scientist.
Cheaper Anti-cancer Drug as Effective as Expensive Drug in Treating Wet AMD
An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose..
Cheaper anti-cancer drug as effective as expensive drug in treating wet AMD
An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.